Acrivon Therapeutics, Inc. (ACRV)
(Delayed Data from NSDQ)
$9.36 USD
+0.67 (7.71%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $9.25 -0.11 (-1.18%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.56 |
EPS Last Quarter | -0.52 |
Last EPS Surprise | 11.86% |
ABR | 1.22 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.40 |
Next Year | -2.64 |
EPS (TTM) | -2.77 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 3.09M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 3.09M |
Low Estimate | NA | NA | NA | 3.09M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.56 | -0.58 | -2.40 | -2.64 |
# of Estimates | 5 | 4 | 6 | 6 |
Most Recent Consensus | -0.52 | NA | -2.31 | -3.20 |
High Estimate | -0.52 | -0.54 | -2.25 | -2.16 |
Low Estimate | -0.60 | -0.63 | -2.71 | -3.51 |
Year ago EPS | -0.66 | -0.86 | -2.74 | -2.40 |
Year over Year Growth Est. | 15.15% | 32.56% | 12.41% | -9.73% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 3 | 1 |
Up Last 60 Days | 2 | 2 | 3 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 2 | 1 | 3 | 5 |
Down Last 60 Days | 2 | 1 | 3 | 5 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.56 | -0.58 | -2.40 | -2.64 |
7 Days Ago | -0.56 | -0.58 | -2.40 | -2.64 |
30 Days Ago | -0.59 | -0.63 | -2.47 | -2.55 |
60 Days Ago | -0.59 | -0.63 | -2.47 | -2.55 |
90 Days Ago | -0.59 | -0.63 | -2.47 | -2.55 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.56 | -0.60 | -2.40 | -2.64 |
Zacks Consensus Estimate | -0.56 | -0.58 | -2.40 | -2.64 |
Earnings ESP | 0.00% | -2.43% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.52 | -0.73 | -0.86 | -0.66 | NA |
Estimate | -0.59 | -0.89 | -0.72 | -0.72 | NA |
Difference | 0.07 | 0.16 | -0.14 | 0.06 | 0.04 |
Surprise | 11.86% | 17.98% | -19.44% | 8.33% | 4.68% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more